AAPL vs ACN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Apple exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its intrinsic value of $233.05 and Graham Number of $32.65. While the company demonstrates elite profitability with an ROE of 152.02% and a consistent track record of earnings beats over 25 quarters, valuation metrics are stretched with a PEG ratio of 2.27. The outlook is tempered by bearish insider activity from the CEO and CFO, alongside a technical trend score of 0/100, suggesting a period of consolidation or correction despite strong fundamental growth.
Accenture (ACN) exhibits mixed fundamental health, with a Piotroski F-Score of 4/9 indicating a borderline stable financial position, and no Altman Z-Score available to assess distress risk. The stock trades at a premium to its Graham Number ($116.86) and intrinsic value estimate ($84.7), suggesting valuation is driven by growth expectations rather than conservative safety. Despite strong profitability metrics—ROE of 25.02% and gross margin of 31.97%—earnings growth has turned negative (-1.60% YoY), and recent price performance reflects significant underperformance over 1Y (-39.2%) and 5Y (-20.8%). Analysts remain optimistic with a buy recommendation and a target price of $268.51, but insider activity is neutral, and technical trends are bearish.
Compare Another Pair
Related Comparisons
AAPL vs ACN: Head-to-Head Comparison
This page compares Apple Inc. (AAPL) and Accenture plc (ACN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.